Site Search Results
Search returned 13 results.
-
Phase II trial of VB-111 in Combination with Nivolumab in Patients with Metastatic Colorectal Cancer (mCRC).
Open - RecruitingNCI Protocol ID NCI-20-C-0022Investigator Tim F. Greten, M.D.Share this trial: Referral ContactsContact Name Phone Number Donna Mabry Hrones (link sends e-mail) 240-858-3155 -
Phase II Trial of Combination Immunotherapy in Subjects with Advanced Small Bowel and Colorectal Cancers
Open - RecruitingNCI Protocol ID NCI-20-C-0138Investigator Julius Strauss, M.D.Share this trial: Referral ContactsContact Name Phone Number Elizabeth Lamping (link sends e-mail) 240.760.7966 -
A Single-Arm Phase II Study of Hepatic Artery Infusion Pump Chemotherapy with Floxuridine and Dexamethasone in Combination with Systemic Chemotherapy for Patients with Colorectal Cancer Metastatic to the Liver
Open - RecruitingNCI Protocol ID NCI-18-C-0024Investigator Jonathan M. Hernandez, M.D.
Share this trial: Referral ContactsContact Name Phone Number Maureen Connolly (link sends e-mail) 240-858-3734 -
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
Open - RecruitingNCI Protocol ID NCI-19-C-0039Investigator Jonathan M. Hernandez, M.D. Share this trial: Referral ContactsContact Name Phone Number Maureen Connolly (link sends e-mail) 240-858-3734 -
Phase II Study of Nivolumab (anti-PD1), Tadalafil and Oral Vancomycin in Patients with Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer from Colorectal or Pancreatic Cancers
Open - RecruitingNCI Protocol ID NCI-19-C-0033Investigator Tim F. Greten, M.D. Share this trial: Referral ContactsContact Name Phone Number Donna Mabry Hrones (link sends e-mail) 301-451-4864 -
Phase I/II Study of the Anti-programmed Death Ligand-1 Antibody MEDI4736 in Combination with Olaparib or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Cancers
Open - RecruitingNCI Protocol ID NCI-15-C-0145Investigator Jung-Min Lee, M.D.Share this trial: Referral ContactsContact Name Phone Number Helen Owens (link sends e-mail) 301-435-5612|Irene Ekwede -
Evaluation for NCI Surgery Branch Clinical Research Protocols
Open - RecruitingNCI Protocol ID NCI-99-C-0128Investigator Steven A. Rosenberg, M.D., Ph.D.Share this trial: Referral ContactsContact Name Phone Number Immunotherapy Recruitment Center (link sends e-mail) 866-820-4505 -
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis from Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
Open - Not yet Recruiting Summary Not Yet Available. Call Referral Contact.NCI Protocol ID NCI-21-C-0012Investigator Andrew M. Blakely, M.D.Share this trial: Referral ContactsContact Name Phone Number Cathleen Hannah (link sends e-mail) 240.858.7006 -
A phase 1/2, open label, dose-escalation, safety and tolerability study of NC410 in subjects with advanced or metastatic solid tumors
Open - RecruitingNCI Protocol ID NCI-20-C-0098Investigator Marijo Bilusic, M.D., Ph.D.Share this trial: Referral ContactsContact Name Phone Number Erica Redmond (link sends e-mail) 240.858.3783 -
Tumor, Normal Tissue and Specimens from Patients Undergoing Evaluation or Surgical Resection of Solid Tumors
Open - RecruitingNCI Protocol ID NCI-13-C-0176Investigator Jeremy L. Davis, M.D.Share this trial: Referral ContactsContact Name Phone Number NIH Foregut Team (link sends e-mail) 240-858-3610